Back
Catalyst Pharmaceuticals Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
CPRX
Catalyst Pharmaceuticals
Last Price:
$24.09
Seasonality Move:
6.55%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.64 | Sell |
| 20-day SMA: | 23.22 | Buy |
| 50-day SMA: | 22.83 | Buy |
| 200-day SMA: | 20.52 | Buy |
| 8-day EMA: | 22.88 | Buy |
| 20-day EMA: | 16.37 | Buy |
| 50-day EMA: | 8.74 | Buy |
| 200-day EMA: | 2.56 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.57 | Buy |
| Relative Strength Index (14 RSI): | 56.2 | Buy |
| Chaikin Money Flow: | 991558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.48 - 24.54) | Buy |
| Bollinger Bands (100): | (21.19 - 23.47) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 24.11 while CPRX 8-day simple moving average is 24.64, which is a Sell signal.
-
The stock price of CPRX is 24.11 while Catalyst Pharmaceuticals 20-day SMA is 23.22, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day simple moving average is 22.83 while CPRX share price is 24.11, making it a Buy technically.
-
CPRX stock price is 24.11 and Catalyst Pharmaceuticals 200-day simple moving average is 20.52, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
73
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $24.11. The Score for CPRX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.9B
Price in USD:
24.11
Share Volume:
1.3M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.16
52-Week Low:
14.47
Buy
73
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 24.11 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 24.11 while CPRX 8-day exponential moving average is 22.88, which is a Buy signal.
-
The stock price of CPRX is 24.11 while Catalyst Pharmaceuticals 20-day EMA is 16.37, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 8.74 while CPRX share price is 24.11, making it a Buy technically.
-
CPRX stock price is 24.11 and Catalyst Pharmaceuticals 200-day simple moving average is 2.56, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.37 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is 6.57, suggesting Catalyst Pharmaceuticals is a Buy
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 56.2, which suggest Catalyst Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (21.48 - 24.54), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.19 - 23.47), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.